Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients.

Tiberti N, Matovu E, Hainard A, Enyaru JC, Lejon V, Robin X, Turck N, Ngoyi DM, Krishna S, Bisser S, Courtioux B, Büscher P, Kristensson K, Ndung'u JM, Sanchez JC.

Clin Transl Med. 2013 Jan 7;2(1):1. doi: 10.1186/2001-1326-2-1.

2.

Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.

Tiberti N, Hainard A, Lejon V, Courtioux B, Matovu E, Enyaru JC, Robin X, Turck N, Kristensson K, Ngoyi DM, Vatunga GM, Krishna S, Büscher P, Bisser S, Ndung'u JM, Sanchez JC.

PLoS One. 2012;7(7):e40909. doi: 10.1371/journal.pone.0040909. Epub 2012 Jul 18.

3.

Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.

Tiberti N, Lejon V, Hainard A, Courtioux B, Robin X, Turck N, Kristensson K, Matovu E, Enyaru JC, Mumba Ngoyi D, Krishna S, Bisser S, Ndung'u JM, Büscher P, Sanchez JC.

PLoS Negl Trop Dis. 2013;7(2):e2088. doi: 10.1371/journal.pntd.0002088. Epub 2013 Feb 28.

4.

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.

Hainard A, Tiberti N, Robin X, Lejon V, Ngoyi DM, Matovu E, Enyaru JC, Fouda C, Ndung'u JM, Lisacek F, Müller M, Turck N, Sanchez JC.

PLoS Negl Trop Dis. 2009 Jun 16;3(6):e459. doi: 10.1371/journal.pntd.0000459.

5.

Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.

Kuepfer I, Hhary EP, Allan M, Edielu A, Burri C, Blum JA.

PLoS Negl Trop Dis. 2011 Mar 1;5(3):e968. doi: 10.1371/journal.pntd.0000968.

6.

Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda.

Enyaru JC, Odiit M, Winyi-Kaboyo R, Sebikali CG, Matovu E, Okitoi D, Olaho-Mukani W.

Ann Trop Med Parasitol. 1999 Dec;93(8):817-22.

PMID:
10715675
7.
8.

Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.

Tiberti N, Hainard A, Lejon V, Robin X, Ngoyi DM, Turck N, Matovu E, Enyaru J, Ndung'u JM, Scherl A, Dayon L, Sanchez JC.

Mol Cell Proteomics. 2010 Dec;9(12):2783-95. doi: 10.1074/mcp.M110.001008. Epub 2010 Aug 19.

9.

Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.

Lejon V, Roger I, Mumba Ngoyi D, Menten J, Robays J, N'siesi FX, Bisser S, Boelaert M, Büscher P.

Clin Infect Dis. 2008 Jul 1;47(1):15-22. doi: 10.1086/588668.

10.

Priorities for the elimination of sleeping sickness.

Welburn SC, Maudlin I.

Adv Parasitol. 2012;79:299-337. doi: 10.1016/B978-0-12-398457-9.00004-4. Review.

PMID:
22726645
11.

Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction.

Kyambadde JW, Enyaru JC, Matovu E, Odiit M, Carasco JF.

Bull World Health Organ. 2000;78(1):119-24.

12.

Parasites in the brain? The search for sleeping sickness biomarkers.

Burchmore R.

Expert Rev Anti Infect Ther. 2012 Nov;10(11):1283-6. doi: 10.1586/eri.12.124.

PMID:
23241185
13.

Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.

Fèvre EM, Odiit M, Coleman PG, Woolhouse ME, Welburn SC.

BMC Public Health. 2008 Mar 26;8:96. doi: 10.1186/1471-2458-8-96.

14.

Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.

Maclean L, Odiit M, Sternberg JM.

Trans R Soc Trop Med Hyg. 2006 Mar;100(3):270-5. Epub 2005 Dec 15.

PMID:
16343570
15.

Options for field diagnosis of human african trypanosomiasis.

Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P.

Clin Microbiol Rev. 2005 Jan;18(1):133-46. Review.

16.

The phenomenon of treatment failures in Human African Trypanosomiasis.

Brun R, Schumacher R, Schmid C, Kunz C, Burri C.

Trop Med Int Health. 2001 Nov;6(11):906-14.

17.
18.

IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.

Nyawira Maranga D, Kagira JM, Kinyanjui CK, Muturi Karanja S, Wangari Maina N, Ngotho M.

Clin Dev Immunol. 2013;2013:320509. doi: 10.1155/2013/320509. Epub 2013 Sep 30.

19.

Human African trypanosomiasis in endemic populations and travellers.

Blum JA, Neumayr AL, Hatz CF.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):905-13. doi: 10.1007/s10096-011-1403-y. Epub 2011 Sep 7. Review.

PMID:
21901632
20.

African trypanosomiasis in a British soldier.

Croft AM, Kitson MM, Jackson CJ, Minton EJ, Friend HM.

Mil Med. 2007 Jul;172(7):765-9.

PMID:
17691692
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk